Tissue Engineering for Massive Bone Defects: The Volumetric Scaling Problem and Strategies to Solve It

Area of Science:

• Orthopaedic Surgery
• Biomaterials Science
• Regenerative Medicine

Background:

• Massive segmental bone defects pose significant reconstructive challenges, exceeding the capabilities of conventional fracture treatments.
• Increasing defect size exacerbates limitations in tissue vascularization and biological processes crucial for bone healing.

Purpose of the Study:

• To review and analyze current tissue engineering strategies for large bone defects.
• To evaluate these strategies based on vascularization, osteogenesis, mechanical stability, immune response, neural integration, and manufacturability.

Main Methods:

• Narrative review synthesizing evidence from scaffold design, cell-based therapies, growth factors, and large-animal models.
• Analysis of preclinical data, including ovine tibial models and early human clinical translations.

Main Results:

• No single current approach reliably replicates the necessary biological and mechanical environment for human long bone regeneration.
• Strongest preclinical evidence involves polycaprolactone/β-tricalcium phosphate composites or titanium lattices in ovine models.
• Human data are limited to case reports and small series, often involving hybrid vascularized flap-scaffold reconstructions.

Conclusions:

• Successful clinical translation requires patient-specific constructs addressing vascularization, load sharing, immune compatibility, infection control, and scalable manufacturing.
• Established reconstructive methods remain the standard of care pending robust comparative clinical evidence.
• Hybrid vascularized scaffold strategies are promising translational approaches, not yet definitive solutions.